About this event
- Date and time Tue 20 Sep 2022 from 8:00am to 6:00pm
- Location Royal Society of Medicine
- Organised by Rheumatology and Rehabilitation
This event seeks to provide a detailed background into the field of autoimmune rheumatic diseases enabling participants to appreciate advances made in the past 40 years and the role and contribution Professor David Isenberg and his colleagues have made.
Join us to recognise the contribution Professor David Isenberg and colleagues have made to academic rheumatology in the past 40 years. Attendees will gain insight into the clinical features and outcomes of autoimmune rheumatic diseases (ARD).
This is an opportunity to learn more about the pathogenesis of ARDs and how a better understanding has led to better treatments and outcomes.
During this event, attendees will be able to:
- Learn optimal methods of clinical assessment in the autoimmune rheumatic disease
- Gain a better understanding of the current knowledge of immunopathology
- Identify advances in therapy that have been made in the next decade
Follow us on:
Tickets
Early bird pricing available until 07 August 2022.
Member
| RSM Fellow | RSM Associate | RSM Retired Fellow | RSM Trainee | RSM Student |
|---|---|---|---|---|
| £45.00 | £22.00 | £22.00 | £22.00 | £15.00 |
Non - Member
| Consultant / GP | Non Healthcare Professional | Trainee | AHP / Nurse / Midwife | Student |
|---|---|---|---|---|
| £60.00 | £30.00 | £30.00 | £25.00 | £20.00 |
Agenda
View the programme
Registration, tea and coffee
Welcome and introduction
Professor David Isenberg
Session 1
Chairs: Professor Peter Lydyard and Dr Debajit Sen, Consultant Paediatric, Adolescent and Adult Rheumatologist, University College London Hospitals NHS Foundation Trust and Honorary Clinical Professor, Division of Medicine, University College London
Long term outcomes in the University College London Hospitals lupus cohort
Professor Anisur Rahman, Professor of Rheumatology, University College London Hospitals NHS Foundation Trust
Memories of myositis
Professor Jo Cambridge
Muscle, music and matches
Professor Mike Hanna
David and Fred’s excellent adventures in myositis
Professor Fred Miller
Developing obstetric rheumatology: From here to maternity
Professor Ian Giles, Professor of Rheumatology, Centre for Rheumatology Research, University College London
DOACs and APS: Back to the future
Professor Hannah Cohen
Tea and coffee break
Session 2
Chairs: Professor John Morrow, Human Microbiome Centre, King’s College London and Professor Pat Woo, Professor Pat Woo, Emeritus Professor, Paediatric Rheumatology, University College London
What have fats got to do with it?
Professor Liz Jury
Making a song and dance about steroids
Professor Liz Lightstone
B cell depletion therapy: past, present and future
Dr Ed Vital, Associate Professor, School of Medicine, University of Leeds
Advancing knowledge in SLE: The game is about glory
Professor Ian Bruce
Clinical coronary artery disease in SLE: Newer concepts
Professor Murray Urowitz, Professor of Medicine, University of Toronto
Lupus: Tracking the butterfly and the wolf
Professor Caroline Gordon, Emeritus Professor of Rheumatology, University of Birmingham
Lunch
Session 3
Chairs: Professor Peter Maddison and Dr Michael Snaith
David and the adolescent journey
Professor Lucy Wedderburn
The ABC of lupus: Antibodies, brains and colleagues
Professor Betty Diamond, Professor, Feinstein Institutes for Medical Research
Cognitive dysfunction in SLE: Single-center cohort presentation
Dr Raquel Faria
To: David Isenberg From: The SLICCest view
Dr Rosalind Ramsey-Goldman
Exeunt lupus, Sjögren’s, MCTD: Has the time come for a new taxonomy?
Professor Ronald Van Vollenhoven, Professor and Chair, Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Centers and Director, Amsterdam Rheumatology Center, Netherlands
Tea and coffee break
Session 4
Dr Isenberg I presume: A chance meeting in the jungle of lupus trials
Dr Joan Merrill, Professor of Medicine, Oklahoma Medical Research Foundation, University of Oklahoma
Natural autoantibodies to type-I interferons normalize blood IFNa and B cell subsets abnormality in lupus patients
Professor Claudia Mauri
Solar power: The sun and lupus
Dr Keith Elkon
Can 'Haifa Road' be a substitute for Abbey Road?
Professor Alexandra Balbir-Gurman, Director, Rheumatology Institute, Ramjbam Health Care Campus
Advances in the treatment of rheumatoid arthritis - the next 50 years
Professor John Isaacs, Professor of Clinical Rheumatology, Newcastle University and Associate Medical Director, Research, Newcastle upon Tyne Hospitals NHS Foundation Trust
Lupus in Africa: A unicorn?
Dr Dzifa Dey, Senior Lecturer, University of Ghana Medical School and Consultant Rheumatologist, Korlebu Teaching Hospital, Accra, Ghana
Back to the future: When this baby hits autoantibodies you are going to see some serious (SLE)DAI
Professor Michael Ehrenstein, Professor of Experimental Rheumatology, University College London and Honorary Consultant Rheumatologist, University College London Hospitals NHS Foundation Trust
Closing remarks
Professor David Isenberg
Close of meeting
Drinks reception
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom